Literature DB >> 16289466

Plasmodium yoelii: axenic development of the parasite mosquito stages.

Johanna M Porter-Kelley1, Rhoel R Dinglasan, Uzma Alam, George A Ndeta, John B Sacci, Abdu F Azad.   

Abstract

Study of the parasite mosquito stages of Plasmodium and its use in the production of sporozoite vaccines against malaria has been hampered by the technical difficulties of in vitro development. Here, we show the complete axenic development of the parasite mosquito stages of Plasmodium yoelii. While we demonstrate that matrigel is not required for parasite development, soluble factors produced and secreted by Drosophila melanogaster S2 cells appear to be crucial for the ookinete to oocyst transition. Parasites cultured axenically are both morphologically and biologically similar to mosquito-derived ookinetes, oocysts, and sporozoites. Axenically derived sporozoites were capable of producing an infection in mice as determined by RT-PCR; however, the parasitemia was significantly much less than that produced by mosquito-derived sporozoites. Our cell free system for development of the mosquito stages of P. yoelii provides a simplified approach to generate sporozoites that may be for biological assays and genetic manipulations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289466     DOI: 10.1016/j.exppara.2005.09.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

Review 1.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

Review 2.  Plasmodium Sporozoite Biology.

Authors:  Friedrich Frischknecht; Kai Matuschewski
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

3.  Plasmodium berghei sporozoites acquire virulence and immunogenicity during mosquito hemocoel transit.

Authors:  Yuko Sato; Georgina N Montagna; Kai Matuschewski
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

Review 4.  A research agenda for malaria eradication: basic science and enabling technologies.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

5.  Bioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds.

Authors:  Raquel Azevedo; Marija Markovic; Marta Machado; Blandine Franke-Fayard; António M Mendes; Miguel Prudêncio
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 6.  The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria.

Authors:  Leslie S Itsara; Yaxian Zhou; Julie Do; Alexis M Grieser; Ashley M Vaughan; Anil K Ghosh
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

7.  NPC1161B, an 8-Aminoquinoline Analog, Is Metabolized in the Mosquito and Inhibits Plasmodium falciparum Oocyst Maturation.

Authors:  Timothy Hamerly; Rebecca E Tweedell; Bernadette Hritzo; Vincent O Nyasembe; Babu L Tekwani; N P Dhammika Nanayakkara; Larry A Walker; Rhoel R Dinglasan
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

8.  Minimum requirements for ookinete to oocyst transformation in Plasmodium.

Authors:  Victoria Carter; Adéla M L Nacer; Ann Underhill; Robert E Sinden; Hilary Hurd
Journal:  Int J Parasitol       Date:  2007-03-30       Impact factor: 3.981

9.  PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro.

Authors:  Leslie S Itsara; Yaxian Zhou; Julie Do; Samrita Dungel; Matthew E Fishbaugher; Will W Betz; Thao Nguyen; Mary Jane Navarro; Erika L Flannery; Ashley M Vaughan; Stefan H I Kappe; Anil K Ghosh
Journal:  Malar J       Date:  2018-04-02       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.